Page 4,735«..1020..4,7344,7354,7364,737..4,7404,750..»

The American Society for Aesthetic Plastic Surgery Named 2013 ACE Award Winner in Social Media Category

Posted: Published on December 23rd, 2013

New York, NY (PRWEB) December 23, 2013 Ragan Communications and PR Daily, producers of the prestigious ACE awards (Awarding Communication Excellence), has named The American Society for Aesthetic Plastic Surgery (ASAPS) winner of the 2013 Award for its effort in changing perceptions of the plastic surgery industry using social media. The ACE Award honors individuals, agencies and in-house teams who have used communication to overcome obstacles. What impressed us about the communications team at ASAPS is how it uses social media to change perceptions about the aesthetic plastic surgery industry, said Tyler Landry, Award Programs Manager at Ragan Communications. The public has historically viewed aesthetic plastic surgery quite skeptically, but the ASAPS team employs Facebook, Twitter, Pinterest, and its blog to share information about plastic surgery so patients can make informed decisions. We congratulate the team for its effort in changing perceptions of the plastic surgery industry. The ACE 2013 Award is a testament of the Aesthetic Societys continued effort to serve the public by providing accurate and timely information regarding aesthetic (cosmetic) plastic surgery and promoting patient safety, said Dr. Jack Fisher, President of the Aesthetic Society. I am delighted that these new methods of communications are being used … Continue reading

Posted in Aesthetic Surgery | Comments Off on The American Society for Aesthetic Plastic Surgery Named 2013 ACE Award Winner in Social Media Category

Adult Stem Cell Therapy | Orthopedic Stem Cell Institute

Posted: Published on December 23rd, 2013

Our state-of- the- art Orthopedic Stem Cell Institute, at the base of the breathtaking Rocky Mountains, in Johnstown, Colorado, uses our own developing research to provide adult stem cell therapies promoting natural healing. We offer two revolutionary non-invasive treatments, Stem Cell therapy and Platelet Rich Plasma (PRP), which are transforming the lives of athletes and everyday people suffering with Spine and Orthopedic injuries caused by aging and degeneration. Dr. Kenneth Pettine, a world renowned spine surgeon and a pioneer in spinal stem cell therapy opened OSCI for patients seeking possible alternatives to surgery. Pettine and his staff treat patients from around the world, using the newest and most advanced technology to treat a number of conditions, including:knees, hips, spine, shoulders, feet and ankles, and other joints. Our adult stem cell therapyprocedureuses adult mesenchymal, multipotent stem cells taken from a patients own bone marrow and then injected back into the same patient into the injured, damaged, or painful area. For patients in Colorado or anywhere in the United States, we can help.About Adult Stem Cell Therapy Read this article: Adult Stem Cell Therapy | Orthopedic Stem Cell Institute … Continue reading

Comments Off on Adult Stem Cell Therapy | Orthopedic Stem Cell Institute

Stem Cell Therapy in Miami Florida – Stem Cell Treatment …

Posted: Published on December 23rd, 2013

erectile dysfunction treatment, type 2 diabetes treatment, arthritis cure, cure for arthritis, therapy for autism, Vision loss therapy, hair loss treatment, preventing hair loss, Pumonary disease therapy, Kidney diseases CellTherapyFlorida U.S. Program and PRP Therapy are now being applied towards painful, injured and inflammatory conditions facilitating healing of muscle, tendons, ligaments, articular and meniscal injuries. Loss of Hair Your own stem cells from a small area of adipose (fat) tissue can be isolated and activated. Together with a PRP and growth factors from a small sample of blood, it can be locally injected into the scalp for male and female pattern hair loss treatment. A single treatment of Stem Cells can be of a long-term benefit. Other therapies and drugs are an hours-to-days alternative! The utilization of insulin in the conventional treatment of diabetes mellitus is only a "symptomatic" approach, and curing diabetes involves a great deal more. Due to the fact most of the diseases that lead to loss of vision do so as a result of abnormal vasculature and/or nerve degeneration, the use of stem cells to stabilize or prevent visual loss holds great promise. Autism is characterized by abnormalities in social interaction, impaired verbal and nonverbal communication, … Continue reading

Comments Off on Stem Cell Therapy in Miami Florida – Stem Cell Treatment …

Spinal Muscular Atrophy Stem Cell Research

Posted: Published on December 23rd, 2013

FSMA-Funded Stem Cell Research Click here for a summary article in Regenerative Medicine on the potential of Stem Cell Therapy for ALS & SMA. Current Project Status: -In 2010, California Stem Cell, Inc submitted an IND application to the FDA for MotorGraft to begin clinical trials in infants with SMA. Please click here for the announcement. -In 2011, the FDA placed the MotorGraft Program on clinical hold, in order to obtain additional data. Please click here for the announcement. The filing of an IND application is the first step in a long, complicated process aimed ultimately at approval of a new therapy. A clinical hold is an order issued by the FDA to a sponsor to delay a proposed trial to obtain more data. California Stem Cell is actively working on collecting the new data requested by the FDA. Please click here for more on the clinical trial process. Past Program Milestones: -The Kerr lab publishes studies showing motor neurons from mouse embryonic stem cells provided therapeutic benefit in a rodents. Please click here for the paper. -Production of motor neurons from human embryonic stem cells are published (See Figure 1). The product is called MotorGraft. Please click here for … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Spinal Muscular Atrophy Stem Cell Research

PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of …

Posted: Published on December 23rd, 2013

Primary Outcome Measures: Safety [TimeFrame:Through 2 years] [Designatedassafetyissue:Yes] Secondary Outcome Measures: Pulmonary Function Tests [TimeFrame:Through 1 year] [Designatedassafetyissue:No] Exercise Capability [TimeFrame:Through 1 year] [Designatedassafetyissue:No] Quality of life [TimeFrame:Through 1 year] [Designatedassafetyissue:No] COPD is currently the fourth leading cause of death in the United States. It is clear that there is a significant unmet medical need for safe and effective therapies to treat moderate to severe COPD. This patient population has a high mortality rate and requires frequent hospitalizations due to disease-related exacerbations. Based on severity distribution estimates, approximately 70% of all current COPD patients have either moderate or severe COPD. COPD has no known cure, thus current therapeutic intervention is aimed at providing relief of symptoms. Oxygen therapy is the only treatment that has been shown to improve survival. Smoking cessation has been shown to slow the rate of FEV1 decline and COPD progression. In general patients are treated with bronchodilators and inhaled corticosteroids, but again, these measures do not provide any significant benefit regarding disease progression or prognosis. The characteristics and biologic activity of PROCHYMAL, along with a good safety profile in human trials to date, suggest that PROCHYMAL may be a good candidate for addressing this unmet medical … Continue reading

Posted in Stem Cell Human Trials | Comments Off on PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of …

CD47 – Research and Clinical Trials – Institute for Stem Cell …

Posted: Published on December 23rd, 2013

CD47 is a kind of protein that is found on the surface of many cells in the body. It tells circulating immune cells called macrophages not to eat these cells. The body uses the CD47 protein to protect cells that should be protected and to help dispose of cells that are aged or diseased. For instance, red blood cells start off with a lot of CD47 on their cell surface when young but slowly lose CD47 as they age. At some point, the amount of CD47 on the surface of an aging red blood cells is not enough to stave off the macrophages, and those older cells are devoured and destroyed, making way for new red blood cells. In this way, the supply of fresh blood cells is constantly replenished. Unfortunately, some cells that should be destroyed are not. Researchers at Stanford have discovered that nearly every kind of cancer cell has a large amount of CD47 on the cell surface. This protein signal protects the cancer against attack by the body's immune system. Stanford investigators have discovered if that they block the CD47 "don't-eat-me" signal through the use of anti-CD47 antibodies, macrophages will consume and destroy cancer cells. Deadly … Continue reading

Posted in Stem Cell Human Trials | Comments Off on CD47 – Research and Clinical Trials – Institute for Stem Cell …

Katrina Brown on BBC Radio Gloucester talking about systemic sclerosis and stem cell treatment. – Video

Posted: Published on December 23rd, 2013

Katrina Brown on BBC Radio Gloucester talking about systemic sclerosis and stem cell treatment. BBC Radio Gloucester Katrina on the Steve Kitchen Show talks about systemic sclerosis. By: Katrinas Future … Continue reading

Comments Off on Katrina Brown on BBC Radio Gloucester talking about systemic sclerosis and stem cell treatment. – Video

Hospital’s stroke team wins two top awards

Posted: Published on December 22nd, 2013

Hospitals stroke team wins two top awards 6:00am Thursday 28th November 2013 in Castle Point A LIFESAVING group of doctors and nurses are celebrating winning two national awards in a month. Southend Hospitals stroke team won first place at the finals of the prestigious Health Service Journal 2013 awards, and was described by judges as an outstanding example of high quality service. The multidisciplinary stroke team won in the secondary care service redesign category for its mini stroke service, an innovative system which speeds up access to specialist assessment and treatment for stroke patients. The news came just a month after the team took the trophy for best use of IT to support clinical treatment and care at the finals of the national E-Health Insider awards. Lead stroke consultant Dr Paul Guyler said: We are delighted to have to won again as this is another example of the expertise and innovation we have developed in the team to improve stroke services to patients. It is extremely gratifying that everyones hard work and dedication has been recognised nationally. But, the real reward for us is the fact patients are receiving immediate treatment to reduce their chances having a life-changing stroke. Clinicians … Continue reading

Comments Off on Hospital’s stroke team wins two top awards

Act fast when stroke symptoms appear

Posted: Published on December 22nd, 2013

Time is of the essence. Its a clich attached to many situations, but none so important, as when a person is having a stroke. So, why is quick treatment so vital? Its because the treatment for the stroke type that accounts for the vast majority of all strokes can only be effective if given within a certain time frame. Just a few hours can make the difference between recovery or learning to walk and talk again - or death. What is a Stroke? One of the most common statements I have heard from people who did not come immediately to the hospital is, Well, doc, I went to bed because I thought I could sleep it off and I would feel better when I woke up. You dont want to try and sleep off symptoms of stroke. What makes a stroke such a serious condition? A stroke is an interruption of blood flow in the brain. When the blood supply is restricted or cut off, brain cells can die. The activities controlled by these cells, such as walking and talking, can be severely impeded. There are two types of strokes. One is called a hemorrhagic stroke, which occurs when a … Continue reading

Comments Off on Act fast when stroke symptoms appear

The Role of Mesenchymal Stem Cells in treatment of Transverse Myelitis – Video

Posted: Published on December 22nd, 2013

The Role of Mesenchymal Stem Cells in treatment of Transverse Myelitis Barbara Krynska, MS, PhD | Shriners Hospitals Pediatric Research Center and Temple University 2013 Rare Neuro-Immunologic Disorders Symposium Repair and Recovery, Today and in the Future... By: transversemyelitis … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on The Role of Mesenchymal Stem Cells in treatment of Transverse Myelitis – Video

Page 4,735«..1020..4,7344,7354,7364,737..4,7404,750..»